SOT 2020 has been cancelled due to COVID-19. We are sorry to miss you this year! SCIREQ is invested in respiratory research and it is our mission to provide pulmonary research scientists with innovative equipment to help them understand, treat, and eradicate lung disease. SCIREQ was looking forward to attending SOT 2020 this year and revealing our exciting announcement with the Fraunhofer ITEM.
Interested in Air-Liquid Interface Exposure?
The Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM) and SCIREQ are pleased to announce their collaboration for the development and commercialization of the ExpoCube platform. Combining optimized computational fluid dynamics and thermophoresis, the ExpoCube offers uniform, reproducible, precision exposures with greatly increased particulate deposition efficiency
Fraunhofer ITEM
The integration of theExpoCubewith SCIREQ’sinExpose® inhalation exposure platform will allow researchers to combine in vitro and in vivo modelling, resulting in an effective use of compounds and better compliance with the 3Rs principle (replace, reduce, refine).
Our compact inhalation exposure system, the inExpose, can be configured to generate and deliver a variety of exposure types, including: cigarette smoke, nebulized aerosols, dry powders and E-cigarette vapor.
The inExpose offers fully programmable, automated puffing with a 3rd Generation push button-activated device (JoyTech VTC Mini) or Electronic Nicotine Delivery Systems (ENDS) devices, such as JUUL, IQOS, RUBI etc., which are pod-based and puff activated.
